Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease

Mallika Modak, Molly A. Frey, Sijia Yi, Yugang Liu, Evan A. Scott

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Cardiovascular disease (CVD) is a leading cause of global mortality, accounting for pathologies that are primarily of atherosclerotic origin and driven by specific cell populations. A need exists for effective, non-invasive methods to assess the risk of potentially fatal major adverse cardiovascular events (MACE) before occurrence and to monitor post-interventional outcomes such as tissue regeneration. Molecular imaging has widespread applications in CVD diagnostic assessment, through modalities including magnetic resonance imaging (MRI), positron emission tomography (PET), and acoustic imaging methods. However, current gold-standard small molecule contrast agents are not cell-specific, relying on non-specific uptake to facilitate imaging of biologic processes. Nanomaterials can be engineered for targeted delivery to specific cell populations, and several nanomaterial systems have been developed for pre-clinical molecular imaging. Here, we review recent advances in nanoparticle-mediated approaches for imaging of cellular processes in cardiovascular disease, focusing on efforts to detect inflammation, assess lipid accumulation, and monitor tissue regeneration.

Original languageEnglish (US)
Pages (from-to)59-68
Number of pages10
JournalCurrent Opinion in Biotechnology
StatePublished - Dec 2020

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering


Dive into the research topics of 'Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease'. Together they form a unique fingerprint.

Cite this